Sverre Slaastad – Country Manager PharmaRelations Norway
Sverre Slaastad takes over as Country Manager PharmaRelations Norway in a period of strong growth for the company. Sverre Slaastad has extensive experience from most parts of Life Science in Norway, including pharmaceuticals and Medtech. Sverre has had leadning commercial and line positions in many well-known companies in Norway over the past decades. With a background from Philips Helathcare as Nordic Marketing Manager, from Baxter Healthcare as Nordic Growth Director, from Sanofi in various commercial positions over a long period of time, from Novo Nordisk as BUM and from Pfizer as product manager, Sverre has had Nordic exposure and experience and his focus is on growth and sales.
“ I am very pleased that Sverre has accepted to lead our Norwegian business in the next phase of growth, his growth and sales mindset are important factors as is his tremendous experience and network in the Norwegian market. PharmaRelations is working across the Nordics within five talent service areas and we are on our way to build a Talent Hub for Life Science in Norway supported by expertise not only in Norway but also from Stockholm, Copenhagen and Helsinki” says Fredrik Anjou, CEO of PharmaRelations.
“ I am happy to take on the role as Country Head Norway at a time when the company is growing fast and my sales focus will thrive. PharmaRelations has a company culture that I appreciate, creating value for our clients and growing and developing our employees are important motivators for me, ” says Sverre Slaastad. Contact Sverre Slaastad +47 909 52 128, firstname.lastname@example.org
Thanks to Kjetil Berg for a fantastic start for PharmaRelations
“ I want to take the opportunity to thank Kjetil Berg for his fantastic period as Country Manager Norway. He started our business in Norway and has developed the company in an admirable way. We love entrepreneurs in PharmaRelations and Kjetil has been a star entrepreneur, a role model. We are sorry that he has decided to pursue new opportunities, but wish him the best of luck in doing so.” says Fredrik Anjou.